Aipuqiang Proton Therapy System at the Cancer Proton Center of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

The Aipuqiang proton therapy system at the Cancer Proton Center of Shanghai Ruijin Hospital officially entered clinical application in November 2023. As of now, over 600 patients have been treated with a local control rate of 100%, and there have been no adverse reactions of grade three or above, demonstrating good effectiveness and safety. The treatment effect is good, truly realizing the independent, controllable, non-invasive and effective treatment of high-end proton therapy devices, benefiting domestic cancer patients.

2025 - 04

Project data

As of March 14, 2025

  • 511

    511 cases completed proton radiotherapy

  • 39

    39 cases in radiotherapy

  • 32

    Waiting for radiotherapy in 32 cases

Completed radiotherapy/case

Complete 28 cases by 2023
Complete 397 cases by 2024
Complete 86 cases by 2025
  • 500
  • 400
  • 300
  • 200
  • 100
  • 0
  • 28 cases

    In 2023

  • 397 cases

    In 2024

  • 86 cases

    In 2025

Contact Us

Proton radiotherapy is the development trend of precision cancer treatment in the future
According to the construction requirements of the hospital proton center, please contact us to tailor a one-stop proton therapy system solution for you

Building domestic high-end particle therapy technology, benefiting cancer patients, and supporting the Healthy China strategy
  • Email

    marketing@aptr.com.cn

  • Address

    605 Xingwen Road, Jiading District, Shanghai

  • Tel/Fax

    +86-21-59559737/+86-21-69152669

Copyright © 2025 Shanghai APACTRON Particle Equipment Co., Ltd.